diethylcarbamazine has been researched along with novobiocin in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bansal, I; Chauhan, PM; Katiyar, SB; Saxena, JK | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chauhan, PM; Kumar, A; Saxena, JK | 1 |
5 other study(ies) available for diethylcarbamazine and novobiocin
Article | Year |
---|---|
Syntheses of 2,4,6-trisubstituted pyrimidine derivatives as a new class of antifilarial topoisomerase II inhibitors.
Topics: Animals; Filaricides; Pyrimidines; Setaria Nematode; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2005 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Synthesis of 4-amino-5-cyano-2, 6-disubstituted pyrimidines as a potential antifilarial DNA topoisomerase II inhibitors.
Topics: Animals; Diethylcarbamazine; Filaricides; Indicators and Reagents; Magnetic Resonance Spectroscopy; Nalidixic Acid; Novobiocin; Pyrimidines; Setaria Nematode; Spectrometry, Mass, Fast Atom Bombardment; Spectrophotometry, Infrared; Spectroscopy, Fourier Transform Infrared; Topoisomerase II Inhibitors | 2008 |